GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Life Stem Genetics LIFS · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 3 Nov 2026, in USD

About Life Stem Genetics

Its shares trade under the ticker LIFS. It has been listed since 11 April 2013.

Life Stem Genetics, Inc. engages in the operation of stem cell therapy based clinics. The company is headquartered in Beverly Hills, California. The company went IPO on 2013-04-11. The firm intends to offer their treatments through a series of affiliate doctors, and medical clinics, with approximately 60 affiliated clinics. The Stem Cells heal various ailments and are being offered as a way to treat various illnesses ranging from orthopedic injuries, neurological disorders, such as Parkinson's, Alzheimer's, Cancer, Plastic Surgery, Age Management, Arthritis, Diabetes, Cardiology, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis and Urology. LISF's Stem Cell Therapy and techniques help to repair or re-program damaged or diseased tissues and organs.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
11 Apr 2013
Employees
1

Leadership

Pay as last reported

  • Dr. Vino PadayacheeChairman of the Board, since 2014
  • Gloria SimovPresident, Chief Executive Officer, Director, since 2013
  • Heather SharpChief Financial Officer, Director, since 2013

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Life Stem Genetics Inc possesses several strengths that contribute to its competitive advantage in the market:

Weaknesses

  • Despite its strengths, Life Stem Genetics Inc is faced with certain weaknesses that may hinder its growth and performance:

Opportunities

  • Life Stem Genetics Inc can leverage the following opportunities to enhance its market position and drive growth:

Threats

  • Life Stem Genetics Inc should be cautious of the following threats that may pose challenges to its success:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.